Loading…

Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin

Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population. In this mixed-methods st...

Full description

Saved in:
Bibliographic Details
Published in:Harm reduction journal 2022-12, Vol.19 (1), p.142-11, Article 142
Main Authors: Tilhou, Alyssa Shell, Birstler, Jen, Baltes, Amelia, Salisbury-Afshar, Elizabeth, Malicki, Julia, Chen, Guanhua, Brown, Randall
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23
cites cdi_FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23
container_end_page 11
container_issue 1
container_start_page 142
container_title Harm reduction journal
container_volume 19
creator Tilhou, Alyssa Shell
Birstler, Jen
Baltes, Amelia
Salisbury-Afshar, Elizabeth
Malicki, Julia
Chen, Guanhua
Brown, Randall
description Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population. In this mixed-methods study employing semi-structured open-ended interviews (n = 29) and a structured survey (n = 341), we examined characteristics associated with test strip use, characteristics of test strip use, and situational, logistical and psychosocial factors influencing test strip use. Respondents were recruited from a syringe service program in southern Wisconsin. Bivariate tests of association and multivariable logistic regression examined the relationship between respondent characteristics and test strip use. Summary statistics were used to describe how situational, logistical and psychosocial factors impact test strip use. Most respondents were male (59.6%), non-Hispanic white (77.4%), young (mean 35.7 years), reported heroin as their primary drug (70.7%), injection as their primary route (87.9%), and use ≥ 3 times daily (78.6%). In multivariable models, site, race and ethnicity, drug of choice, and seeking fentanyl were associated with test strip use. Among test strip users, 36.5% use them most of the time or more and 80.6% get positive results half the time or more. Among individuals reporting heroin, fentanyl, methamphetamine, or cocaine or crack cocaine at least once per month, 99.1%, 56.8%, 42.2%, and 55.7% reported testing these drugs, respectively. Test strip use is supported by information from suppliers, regular transportation, diverse distribution locations, recommendations from harm reduction staff, and having a safe or private place to use. We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.
doi_str_mv 10.1186/s12954-022-00720-7
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1e4c4442ff84455695fef4e9f03310c5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A730261337</galeid><doaj_id>oai_doaj_org_article_1e4c4442ff84455695fef4e9f03310c5</doaj_id><sourcerecordid>A730261337</sourcerecordid><originalsourceid>FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbK3-AS8k4PXUfE5mboSy-FEoeKN4GbKZk9ksM8maZIv77z3t1toFyUXCyfs-nHN4m-Yto5eM9d2HwvigZEs5bynVnLb6WXPOpNatVkw_f_I-a16VsqUU9aJ_2ZyJTnGutT5vtquNzdZVyKHU4AqxcSQuxQq_K0meeIjVxsNMKpRKSs1hR_YFiF1SnEg55BAnIAXybXBA3BxQX0iIpKR93UCO5GcoyCshvm5eeDsXePNwXzQ_Pn_6vvra3nz7cr26ummd6kRtR-_6jls1UqY714_Uwtox6tfCDW4QVGjgvodB9WvVOei5Y71yMKANrBy5uGiuj9wx2a3Z5bDYfDDJBnNfSHkyNuOsMxgG0kkpufe9lEp1g_LgJbKoEIw6hayPR9Zuv15gdDhdtvMJ9PQnho2Z0q0ZtBJCSQS8fwDk9GuPOzTbtM8R5zdcK6V1R3n3TzVZ7CpEnxDmFtycudICFUwIjarL_6jwjLAE3DH4gPUTAz8aXE6lZPCPjTNq7iJkjhEyGCFzHyFzZ3r3dORHy9_MiD9ibsNO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2755776026</pqid></control><display><type>article</type><title>Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>NCBI_PubMed Central(免费)</source><source>Coronavirus Research Database</source><creator>Tilhou, Alyssa Shell ; Birstler, Jen ; Baltes, Amelia ; Salisbury-Afshar, Elizabeth ; Malicki, Julia ; Chen, Guanhua ; Brown, Randall</creator><creatorcontrib>Tilhou, Alyssa Shell ; Birstler, Jen ; Baltes, Amelia ; Salisbury-Afshar, Elizabeth ; Malicki, Julia ; Chen, Guanhua ; Brown, Randall</creatorcontrib><description>Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population. In this mixed-methods study employing semi-structured open-ended interviews (n = 29) and a structured survey (n = 341), we examined characteristics associated with test strip use, characteristics of test strip use, and situational, logistical and psychosocial factors influencing test strip use. Respondents were recruited from a syringe service program in southern Wisconsin. Bivariate tests of association and multivariable logistic regression examined the relationship between respondent characteristics and test strip use. Summary statistics were used to describe how situational, logistical and psychosocial factors impact test strip use. Most respondents were male (59.6%), non-Hispanic white (77.4%), young (mean 35.7 years), reported heroin as their primary drug (70.7%), injection as their primary route (87.9%), and use ≥ 3 times daily (78.6%). In multivariable models, site, race and ethnicity, drug of choice, and seeking fentanyl were associated with test strip use. Among test strip users, 36.5% use them most of the time or more and 80.6% get positive results half the time or more. Among individuals reporting heroin, fentanyl, methamphetamine, or cocaine or crack cocaine at least once per month, 99.1%, 56.8%, 42.2%, and 55.7% reported testing these drugs, respectively. Test strip use is supported by information from suppliers, regular transportation, diverse distribution locations, recommendations from harm reduction staff, and having a safe or private place to use. We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.</description><identifier>ISSN: 1477-7517</identifier><identifier>EISSN: 1477-7517</identifier><identifier>DOI: 10.1186/s12954-022-00720-7</identifier><identifier>PMID: 36522777</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Analgesics, Opioid ; Bivariate analysis ; Cocaine ; Data collection ; Drug abuse ; Drug addicts ; Drug overdose ; Drug Overdose - prevention &amp; control ; Drug testing ; Drug use ; Drugs ; Ethnicity ; Female ; Fentanyl ; Fentanyl test strip (FTS) ; Harm reduction ; Health aspects ; Heroin ; Humans ; Impact tests ; Interviews ; Male ; Methamphetamine ; Minority &amp; ethnic groups ; Narcotics ; Opioid ; Overdose ; Penetration ; Polls &amp; surveys ; Psychological aspects ; Recruitment ; Social aspects ; Strip ; Syringes ; Wisconsin</subject><ispartof>Harm reduction journal, 2022-12, Vol.19 (1), p.142-11, Article 142</ispartof><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23</citedby><cites>FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753354/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2755776026?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,38516,43895,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36522777$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tilhou, Alyssa Shell</creatorcontrib><creatorcontrib>Birstler, Jen</creatorcontrib><creatorcontrib>Baltes, Amelia</creatorcontrib><creatorcontrib>Salisbury-Afshar, Elizabeth</creatorcontrib><creatorcontrib>Malicki, Julia</creatorcontrib><creatorcontrib>Chen, Guanhua</creatorcontrib><creatorcontrib>Brown, Randall</creatorcontrib><title>Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin</title><title>Harm reduction journal</title><addtitle>Harm Reduct J</addtitle><description>Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population. In this mixed-methods study employing semi-structured open-ended interviews (n = 29) and a structured survey (n = 341), we examined characteristics associated with test strip use, characteristics of test strip use, and situational, logistical and psychosocial factors influencing test strip use. Respondents were recruited from a syringe service program in southern Wisconsin. Bivariate tests of association and multivariable logistic regression examined the relationship between respondent characteristics and test strip use. Summary statistics were used to describe how situational, logistical and psychosocial factors impact test strip use. Most respondents were male (59.6%), non-Hispanic white (77.4%), young (mean 35.7 years), reported heroin as their primary drug (70.7%), injection as their primary route (87.9%), and use ≥ 3 times daily (78.6%). In multivariable models, site, race and ethnicity, drug of choice, and seeking fentanyl were associated with test strip use. Among test strip users, 36.5% use them most of the time or more and 80.6% get positive results half the time or more. Among individuals reporting heroin, fentanyl, methamphetamine, or cocaine or crack cocaine at least once per month, 99.1%, 56.8%, 42.2%, and 55.7% reported testing these drugs, respectively. Test strip use is supported by information from suppliers, regular transportation, diverse distribution locations, recommendations from harm reduction staff, and having a safe or private place to use. We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.</description><subject>Analgesics, Opioid</subject><subject>Bivariate analysis</subject><subject>Cocaine</subject><subject>Data collection</subject><subject>Drug abuse</subject><subject>Drug addicts</subject><subject>Drug overdose</subject><subject>Drug Overdose - prevention &amp; control</subject><subject>Drug testing</subject><subject>Drug use</subject><subject>Drugs</subject><subject>Ethnicity</subject><subject>Female</subject><subject>Fentanyl</subject><subject>Fentanyl test strip (FTS)</subject><subject>Harm reduction</subject><subject>Health aspects</subject><subject>Heroin</subject><subject>Humans</subject><subject>Impact tests</subject><subject>Interviews</subject><subject>Male</subject><subject>Methamphetamine</subject><subject>Minority &amp; ethnic groups</subject><subject>Narcotics</subject><subject>Opioid</subject><subject>Overdose</subject><subject>Penetration</subject><subject>Polls &amp; surveys</subject><subject>Psychological aspects</subject><subject>Recruitment</subject><subject>Social aspects</subject><subject>Strip</subject><subject>Syringes</subject><subject>Wisconsin</subject><issn>1477-7517</issn><issn>1477-7517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhgdRbK3-AS8k4PXUfE5mboSy-FEoeKN4GbKZk9ksM8maZIv77z3t1toFyUXCyfs-nHN4m-Yto5eM9d2HwvigZEs5bynVnLb6WXPOpNatVkw_f_I-a16VsqUU9aJ_2ZyJTnGutT5vtquNzdZVyKHU4AqxcSQuxQq_K0meeIjVxsNMKpRKSs1hR_YFiF1SnEg55BAnIAXybXBA3BxQX0iIpKR93UCO5GcoyCshvm5eeDsXePNwXzQ_Pn_6vvra3nz7cr26ummd6kRtR-_6jls1UqY714_Uwtox6tfCDW4QVGjgvodB9WvVOei5Y71yMKANrBy5uGiuj9wx2a3Z5bDYfDDJBnNfSHkyNuOsMxgG0kkpufe9lEp1g_LgJbKoEIw6hayPR9Zuv15gdDhdtvMJ9PQnho2Z0q0ZtBJCSQS8fwDk9GuPOzTbtM8R5zdcK6V1R3n3TzVZ7CpEnxDmFtycudICFUwIjarL_6jwjLAE3DH4gPUTAz8aXE6lZPCPjTNq7iJkjhEyGCFzHyFzZ3r3dORHy9_MiD9ibsNO</recordid><startdate>20221215</startdate><enddate>20221215</enddate><creator>Tilhou, Alyssa Shell</creator><creator>Birstler, Jen</creator><creator>Baltes, Amelia</creator><creator>Salisbury-Afshar, Elizabeth</creator><creator>Malicki, Julia</creator><creator>Chen, Guanhua</creator><creator>Brown, Randall</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PATMY</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PYCSY</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20221215</creationdate><title>Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin</title><author>Tilhou, Alyssa Shell ; Birstler, Jen ; Baltes, Amelia ; Salisbury-Afshar, Elizabeth ; Malicki, Julia ; Chen, Guanhua ; Brown, Randall</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Analgesics, Opioid</topic><topic>Bivariate analysis</topic><topic>Cocaine</topic><topic>Data collection</topic><topic>Drug abuse</topic><topic>Drug addicts</topic><topic>Drug overdose</topic><topic>Drug Overdose - prevention &amp; control</topic><topic>Drug testing</topic><topic>Drug use</topic><topic>Drugs</topic><topic>Ethnicity</topic><topic>Female</topic><topic>Fentanyl</topic><topic>Fentanyl test strip (FTS)</topic><topic>Harm reduction</topic><topic>Health aspects</topic><topic>Heroin</topic><topic>Humans</topic><topic>Impact tests</topic><topic>Interviews</topic><topic>Male</topic><topic>Methamphetamine</topic><topic>Minority &amp; ethnic groups</topic><topic>Narcotics</topic><topic>Opioid</topic><topic>Overdose</topic><topic>Penetration</topic><topic>Polls &amp; surveys</topic><topic>Psychological aspects</topic><topic>Recruitment</topic><topic>Social aspects</topic><topic>Strip</topic><topic>Syringes</topic><topic>Wisconsin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tilhou, Alyssa Shell</creatorcontrib><creatorcontrib>Birstler, Jen</creatorcontrib><creatorcontrib>Baltes, Amelia</creatorcontrib><creatorcontrib>Salisbury-Afshar, Elizabeth</creatorcontrib><creatorcontrib>Malicki, Julia</creatorcontrib><creatorcontrib>Chen, Guanhua</creatorcontrib><creatorcontrib>Brown, Randall</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Environmental Science Database</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Environmental Science Collection</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Harm reduction journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tilhou, Alyssa Shell</au><au>Birstler, Jen</au><au>Baltes, Amelia</au><au>Salisbury-Afshar, Elizabeth</au><au>Malicki, Julia</au><au>Chen, Guanhua</au><au>Brown, Randall</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin</atitle><jtitle>Harm reduction journal</jtitle><addtitle>Harm Reduct J</addtitle><date>2022-12-15</date><risdate>2022</risdate><volume>19</volume><issue>1</issue><spage>142</spage><epage>11</epage><pages>142-11</pages><artnum>142</artnum><issn>1477-7517</issn><eissn>1477-7517</eissn><abstract>Fentanyl adulteration of illicit drugs is a major driver of opioid-involved overdose in the USA. Fentanyl test strips are increasingly used by people who use drugs to check for fentanyl. However, little is known about factors that influence test strip use in this population. In this mixed-methods study employing semi-structured open-ended interviews (n = 29) and a structured survey (n = 341), we examined characteristics associated with test strip use, characteristics of test strip use, and situational, logistical and psychosocial factors influencing test strip use. Respondents were recruited from a syringe service program in southern Wisconsin. Bivariate tests of association and multivariable logistic regression examined the relationship between respondent characteristics and test strip use. Summary statistics were used to describe how situational, logistical and psychosocial factors impact test strip use. Most respondents were male (59.6%), non-Hispanic white (77.4%), young (mean 35.7 years), reported heroin as their primary drug (70.7%), injection as their primary route (87.9%), and use ≥ 3 times daily (78.6%). In multivariable models, site, race and ethnicity, drug of choice, and seeking fentanyl were associated with test strip use. Among test strip users, 36.5% use them most of the time or more and 80.6% get positive results half the time or more. Among individuals reporting heroin, fentanyl, methamphetamine, or cocaine or crack cocaine at least once per month, 99.1%, 56.8%, 42.2%, and 55.7% reported testing these drugs, respectively. Test strip use is supported by information from suppliers, regular transportation, diverse distribution locations, recommendations from harm reduction staff, and having a safe or private place to use. We found that individuals who use fentanyl test strips are more often non-Hispanic white, use heroin, and seek drugs with fentanyl relative to individuals without test strip use. Findings confirm high fentanyl penetration in the Wisconsin drug supply. Low rates of stimulant testing suggest inadequate awareness of fentanyl penetration. Findings support outreach to key populations, increased diversity of distributing locations, efforts to correct misperceptions about drug wasting, emphasis on pre-consumption testing, and the importance of adjunct behaviors to prevent overdose given high rates of intentional fentanyl use.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>36522777</pmid><doi>10.1186/s12954-022-00720-7</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1477-7517
ispartof Harm reduction journal, 2022-12, Vol.19 (1), p.142-11, Article 142
issn 1477-7517
1477-7517
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1e4c4442ff84455695fef4e9f03310c5
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); NCBI_PubMed Central(免费); Coronavirus Research Database
subjects Analgesics, Opioid
Bivariate analysis
Cocaine
Data collection
Drug abuse
Drug addicts
Drug overdose
Drug Overdose - prevention & control
Drug testing
Drug use
Drugs
Ethnicity
Female
Fentanyl
Fentanyl test strip (FTS)
Harm reduction
Health aspects
Heroin
Humans
Impact tests
Interviews
Male
Methamphetamine
Minority & ethnic groups
Narcotics
Opioid
Overdose
Penetration
Polls & surveys
Psychological aspects
Recruitment
Social aspects
Strip
Syringes
Wisconsin
title Characteristics and context of fentanyl test strip use among syringe service clients in southern Wisconsin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A33%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20and%20context%20of%20fentanyl%20test%20strip%20use%20among%20syringe%20service%20clients%20in%20southern%20Wisconsin&rft.jtitle=Harm%20reduction%20journal&rft.au=Tilhou,%20Alyssa%20Shell&rft.date=2022-12-15&rft.volume=19&rft.issue=1&rft.spage=142&rft.epage=11&rft.pages=142-11&rft.artnum=142&rft.issn=1477-7517&rft.eissn=1477-7517&rft_id=info:doi/10.1186/s12954-022-00720-7&rft_dat=%3Cgale_doaj_%3EA730261337%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c563t-dfc862a5d0176c8d0aebc10fb3c9c93037e2f8e958b56ce82c185ce9fc8ea4d23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2755776026&rft_id=info:pmid/36522777&rft_galeid=A730261337&rfr_iscdi=true